MTOR and central nervous system cancer: Inhibition of SOAT1 regulates SLC40A1 through the PI3K/AKT/mTOR pathway, elevating the level of lipid peroxidation in glioma cells and enhancing their sensitivity to ferroptosis inducers and radiotherapy [42].